If you don’t want to attempt to have a genuine good faith conversation, no worries at all.
But you won’t be talking to me.
DYOR, schools out, read the announcements, Lbt have been busy bees the last 18months.
This isn’t a established large cap bio tech with 10 years of sales history. The stock price is currently a meaningless value based on emotional guesswork and has nothing to do with the true value of the company and it’s potentially very bright future.
Sales will decide its true value, and that seems to be pretty close at hand
